ONCAlert | 2017 San Antonio Breast Cancer Symposium

Dr. Luke Discusses the Combination of PD-1 and IDO Inhibitors in Melanoma

Jason Luke, MD
Published Online:4:30 PM, Mon November 6, 2017

Jason Luke, MD, assistant professor of medicine, University of Chicago Medicine, discusses the promising combination of a PD-1 antibody plus an IDO inhibitor for the treatment of patients with melanoma.
 
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.